Sample sizes for trials involving multiple correlated must-win comparisons-Reference-Cited by-同舟云学术

Sample sizes for trials involving multiple correlated must-win comparisons

Published:2012-03 Issue:2 Volume:11 Page:177-185
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceut. Statist.

Author:

Julious Steven A.¹,McIntyre Nikki E.²

Affiliation:

1. University of Sheffield-Medical Statistics Group; Health Services Research, ScHARR University of Sheffield, Regent Court; 30 Regent Steet Sheffield, Yorkshire S14DA United Kingdom

2. Statistics and Programming; AstraZeneca; Alderley Park, Macclesfield SK10 4TG UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pst.515/fullpdf

Reference15 articles.

1. Bioequivalence trials, intersection-union tests and equivalence confidence sets;Berger;Statistical Science,1996

2. Testing for treatment effects on subsets of endpoints;Chen;Biometrical Journal,2002

3. Practical usage of O'Brien's OLS and GLS statistics in clinical trials;Dallow;Pharmaceutical Statistics,2008

4. Power and sample size when multiple endpoints are considered;Senn;Pharmaceutical Statistics,2007

5. Evaluation of the statistical power for multiple tests: a case study;Yeo;Pharmaceutical Statistics,2009

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VIRTUAL BIOEQUIVALENCE IN PHARMACEUTICALS: CURRENT STATUS AND FUTURE PROSPECTS;International Journal of Applied Pharmaceutics;2023-09-07

2. Sample size estimation using a latent variable model for mixed outcome co‐primary, multiple primary and composite endpoints;Statistics in Medicine;2022-02-23

3. When to adjust alpha during multiple testing: a consideration of disjunction, conjunction, and individual testing;Synthese;2021-07-06

4. Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA2 five-stage study, including a workshop;Health Technology Assessment;2019-10

5. Comparison of three sample size calculation methods for non-inferiority vaccine trials with multiple continuous co-primary endpoints;Human Vaccines & Immunotherapeutics;2018-10-04